US Patent Issued to SUMMIT (OXFORD) on June 3 for "Solid tablet dosage form of ridinilazole" (British Inventors)

ALEXANDRIA, Va., June 4 -- United States Patent no. 12,318,487, issued on June 3, was assigned to SUMMIT (OXFORD) Ltd. (Abingdon, Great Britain).

"Solid tablet dosage form of ridinilazole" was invented by Francis X. Wilson (Welwyn Garden, Great Britain), Laura Trespidi (Bramley Tadley Basingstoke, Great Britain), Jean-Francois Carniaux (Abingdon, Great Britain) and Peter Timmins (Ellesmere Port, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to solid tablet oral dosage forms of 2,2'-di(pyridin-4-yl)-1H,1'H-5,5'-bibenzo[d]imidazole (which may also be known as 2,2'-di-4-pyridinyl-6,6'-bi-1H-benzimidazole; 5,5'-bis[2-(4-pyridinyl)-1H-benzimidazole]; 2,2'-bis(4-pyridyl...